News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. grants restricted stock units to new employees as inducement for employment. RSUs vest over one to three years. Company focused on developing pharmaceuticals from rainforest plants for gastrointestinal distress -
-
-
COMMUNIQUÉ DE PRESSE
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present October 16 at BIO Investor Forum
Magdalena plans to submit IND application in early 2025 to FDA for next-generation psychoactive drug for mental health such as ADHD and schizophrenia. Jaguar Health presents at BIO Investor Forum to discuss lead botanical drug candidate MB2500 -
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial
Jaguar Health, Inc. announced a late-breaking abstract on diarrhea management from a placebo group study in breast cancer patients. Further FDA discussions planned
